This inventor holds 3 USPTO granted patents and 4 published patent applications. Top assignees: Rnaimmune, Inc., Changzhou Zhengyuan Medical Technology Co., Ltd., Guangzhou Nanotides Pharmaceuticals Co., Ltd.. Active years: 2019-2025.
Company Filing History:
2 out of 3 
1 out of 1 
1 out of 1 Years Active: 2019-2025
Title: Innovations of Shenggao Tang in mRNA Vaccine Development
Introduction
Shenggao Tang is a prominent inventor based in Guangzhou, CN. He has made significant contributions to the field of mRNA vaccine technology, particularly in the fight against novel coronavirus infections. With a total of 3 patents, his work has been pivotal in advancing vaccine development.
Latest Patents
Shenggao Tang's latest patents include groundbreaking compositions and methods for mRNA vaccines targeting novel coronavirus infections. One of his notable patents describes a ribonucleic acid (RNA) encoding a spike (S) protein or an immunogenic fragment of the severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2), which includes at least one non-naturally occurring amino acid mutation. This innovation is particularly relevant as it addresses the delta variant of the virus. Another patent focuses on potent mRNA vaccines for the prevention and treatment of 2019 novel Coronavirus (2019-nCoV) infections. This composition includes pharmaceutical formulations containing mRNA molecules that encode spike protein epitopes, including mutated variants, and utilizes polymeric and liposomal nanoparticle carriers for effective delivery.
Career Highlights
Throughout his career, Shenggao Tang has worked with notable companies such as Rnaimmune, Inc. and Changzhou Zhengyuan Medical Technology Co., Ltd. His expertise in mRNA technology has positioned him as a key figure in the development of innovative vaccine solutions.
Collaborations
Shenggao Tang has collaborated with esteemed colleagues, including Dong Shen and Chun Lu, to further enhance the research and development of mRNA vaccines. Their combined efforts have contributed to significant advancements in the field.
Conclusion
Shenggao Tang's innovative work in mRNA vaccine development showcases his dedication to addressing global health challenges. His patents and collaborations reflect a commitment to advancing medical science and improving public health outcomes.